Why is SPARC falling/rising?

Recent Price Movement and Market Context

SPARC’s intraday trading on 08-Dec was marked by high volatility, with the stock swinging within a wide range of ₹16.15 and touching a low of ₹137.45, representing a 10.08% drop from previous levels. Despite trading above its 20-day and 50-day moving averages, the stock remains below its 5-day, 100-day, and 200-day averages, signalling mixed technical signals. The weighted average price skewed towards the lower end of the day’s range, indicating selling pressure. Furthermore, investor participation has waned, with delivery volumes on 05 Dec plunging by 57.48% compared to the five-day average, suggesting reduced conviction among shareholders.

Long-Term Underperformance and Weak Fundamentals

SPARC’s share price trajectory over the past year and beyond paints a challenging picture. The stock has declined by 35.82% over the last 12 months and by nearly 42% over three years, starkly contrasting with the Sensex’s gains of 4.15% and 36.01% respectively during the same periods. Year-to-date, the stock is down 30.29%, while the benchmark index has risen by 8.91%. This persistent underperformance underscores the company’s struggles to generate shareholder value in a competitive market environment.

Financial Performance and Profitability Concerns

The company’s financial results have been notably weak, with net sales declining at an annualised rate of 24.65% over the past five years and operating profit shrinking by 1.19% annually. The latest quarterly results, declared in September 2025, were particularly disappointing. Operating profit fell by 6.73%, and the company reported negative earnings for two consecutive quarters. The net sales for the quarter stood at a low ₹7.86 crore, while interest expenses surged to ₹7.52 crore, reflecting a strained financial position.

Moreover, the company’s ability to service its debt is precarious, with an average EBIT to interest ratio of -141.22, signalling that earnings before interest and tax are insufficient to cover interest obligations. The latest six-month period saw a net loss after tax of ₹127.72 crore, worsening by 41.02%, which further dampens investor confidence.

Risk Factors and Market Sentiment

SPARC’s negative book value highlights its weak long-term fundamental strength, making it a risky proposition for investors. The stock’s negative EBITDA and poor profitability metrics have led to valuations that are unattractive compared to historical averages. Despite a modest rise in profits by 34.6% over the past year, the stock’s price has not reflected this, indicating a disconnect between earnings and market sentiment.

Additionally, the stock underperformed the BSE500 index in each of the last three annual periods, reinforcing its status as a laggard within the broader market. The recent price decline on 08-Dec, following two days of gains, suggests a trend reversal driven by these underlying weaknesses and cautious investor behaviour.

Conclusion: Why SPARC Is Falling

The decline in SPARC’s share price on 08-Dec is primarily attributable to its weak financial fundamentals, poor earnings performance, and consistent underperformance relative to market benchmarks. The company’s negative book value, shrinking sales, and inability to cover interest expenses have eroded investor confidence. High intraday volatility and reduced trading volumes further indicate a lack of strong buying interest. While the stock had shown some short-term gains, the reversal on 08-Dec reflects a reassessment by the market of the company’s long-term prospects, which remain uncertain and challenging.

Investors should carefully weigh these factors against their risk appetite and consider alternative opportunities within the pharmaceuticals and biotechnology sector that may offer more robust fundamentals and growth potential.

Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →